Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Conference topics

Home » Conference topics
  • 2023 SGBCC Expert Voting: HER2 Positive, BRCA Associated,  Bone Modifying Therapy, Molecular Diagnosis

    2023.10.24
  • WCLC 2023 : Dr. Wu Yilong, Dr. Cheng Ying, and Dr.Han Baohui Discuss the latest advancements in Small Cell Lung Cancer Research and Analyze the Development of ADC

    2023.10.23
  • WCLC 2023 | Dr. Liu: Immunotherapy Combined Chemotherapy Can Bring Long-term Survival Benefits to ES-SCLC Patients

    2023.10.23
  • WCLC 2023 | Dr. Chen Haiquan: The Asian Perspective on Lung Cancer Screening

    2023.10.23
  • WCLC 2023 | Dr. Han Baohui’s Team Presents Multiple Research Achievements, Making China’s Voice Resonate at WCLC

    2023.10.23
  • WCLC 2023 | Dr. Shi Meiqi: Treatment Strategies for EGFR Mutation and KRAS Mutation Non-Small Cell Lung Cancer

    2023.10.23
  • WCLC Voice of China | Dr. Liang Application of Video-Based Artificial Intelligence in Thoracoscopic Lobectomy for Lung Cancer

    2023.10.23
  • WCLC Voice of China | Dr. Xie Huikang: The Value of Lepidic and Invasion Patterns New Diagnostic Criteriafor the Differential Diagnosis of AIS, MIA from Invasive Adenocarcinoma

    2023.10.23
  • WCLC 2023 |Dr. Zhu Zhengfei: SBRT Combined with Dual Immune Checkpoint Inhibitors for Advanced NSCLC Achieves a Median OS of 34 Months

    2023.10.23
«previous next»
Recent Posts
  • CASH 2026 | Prof. Wang Tianyou: Forty Years of Change in China’s Pediatric Disease Spectrum and Strategic Responses
  • Lymphoma In-Depth · ASH Special | Professor Qingqing Cai: New Advances in First-Line Treatment of Marginal Zone Lymphoma
  • ASH Global Perspectives | Prof. Wojciech Jurczak: First Results of BRUIN CLL-313 Suggest Non-Covalent BTK Inhibitors May Reshape First-Line CLL/SLL Treatment
  • ASH News Flash | Professor Huanling Zhu Highlights Breakthrough Leukemia Studies
  • ASH China Voices | Prof. Yongrong Lai & Prof. Lingling Shi: Validation of the “Guangxi Regimen” for Thalassemia Transplantation
Recent Comments
    Archives
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top